Paradeep Phosphates Ltd
Paradeep Phosphates Ltd
ChemicalsKey Fundamentals
SmallcapFertilizersChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Paradeep Phosphates Ltd insights
46 extracted metrics + investor summaries across FY19–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company has delivered good profit growth of 35.2% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 23.7%
Weaknesses
1- Company has a low return on equity of 13.2% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Paradeep Phosphates Ltd operates in the fertilizer/chemicals sector with a market cap of Rs 15,311 Cr, trading at a PE of 14.3x with 5-year profit CAGR of 35% and TTM sales growth of 28%. The stock has declined 29% over the past year despite maintaining healthy operational growth metrics.
- Strong 5-year compounded profit growth of 35% CAGR demonstrates consistent earnings expansion
- TTM revenue growth of 28% indicates robust top-line momentum in recent quarters
- PE ratio of 14.3x is relatively modest for a company delivering 48% profit CAGR over 3 years
- Last year ROE of 19% shows improved capital efficiency compared to 3-year average of 13%
- 5-year compounded sales growth of 33% reflects sustained demand and market share gains in the phosphatic fertilizer segment
- Healthy dividend payout ratio of 23.7% signals management confidence in cash flow sustainability
- 3-year stock CAGR of 33% indicates meaningful long-term wealth creation despite recent correction
- TTM profit growth of 14% continues to be positive even as the base effect of earlier high-growth years normalizes
- Stock has declined 29% over the past 1 year, significantly underperforming broader market indices
- 3-year average ROE of only 13.2% is below the 15% threshold generally considered attractive for capital-intensive businesses
- Price-to-book ratio of 2.25x may be elevated given the sub-par return on equity of 13% over 3 years
- TTM profit growth of 14% represents a sharp deceleration from the 3-year CAGR of 48%, suggesting growth is slowing
- Dividend yield of only 0.68% provides limited downside protection or income support for investors
- Operating in the fertilizer/chemicals sector exposes the company to subsidy policy risks and raw material price volatility
- Limited 10-year track record data (ROE, sales, profit CAGR not available for 10-year periods) reduces visibility on long-cycle performance
- 5-year ROE of 14% only marginally above cost of equity for a leveraged fertilizer business, indicating thin value creation margins
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 profit surges 24% YoY Jul 28
Standalone net profit rose 24% YoY to ₹392.60 crore in Q1FY27, driven by higher revenue and inventory benefits.
- ₹250 Cr AlF3 plant approved Jul 28
Board approved ₹250 crore investment for a 15,000 MTPA Aluminium Fluoride plant at Paradeep, diversifying into industrial chemicals via HFSA by-product valorisation.
- SC upholds ₹53.50 Cr subsidy release Aug 8
Supreme Court dismissed DoF appeal, directing release of ₹53.50 crore NBS subsidy to Paradeep Phosphates per Delhi HC order.
- Not-for-profit R&D subsidiary formed Aug 5
Board approved incorporation of Fertilizer Innovation Foundation–India as a wholly-owned Section 8 subsidiary focused on fertilizer innovation.
- 44th AGM scheduled Sep 17 Aug 17
AGM set for September 17, 2026 via video conferencing at 3:00 pm. No dividend or financial details disclosed in the notice.
- Stock Option Plan 2026 approved Jul 28
Board approved Performance Stock Option Plan 2026 covering 20 lakh shares at ₹10 face value exercise price, subject to shareholder approval.
- Analyst call transcript uploaded Aug 6
Transcript of July 31, 2026 analyst/investor conference call uploaded to company website per SEBI compliance.
TL;DR: Paradeep Phosphates is firing on multiple cylinders — strong Q1FY27 earnings growth of 24%, a favourable Supreme Court ruling unlocking ₹53.50 crore in subsidy, and a ₹250 crore capex commitment into value-added chemicals. No material headwinds emerged in recent news flow. The trend is clearly improving with earnings momentum, revenue diversification via AlF3, and regulatory wins reinforcing the bullish setup.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,054 | 3,683 | 2,595 | 2,243 | 2,377 | 4,619 | 4,990 | 4,194 | 4,504 | 6,872 | 5,749 | 4,702 | 6,124 |
| Expenses | 3,093 | 3,427 | 2,313 | 2,095 | 2,231 | 4,112 | 4,551 | 3,811 | 3,923 | 6,216 | 5,276 | 4,260 | 5,404 |
| Operating Profit | -39 | 256 | 282 | 148 | 146 | 507 | 438 | 383 | 580 | 657 | 472 | 442 | 720 |
| OPM % | -1.3% | 7% | 11% | 7% | 6% | 11% | 9% | 9% | 13% | 10% | 8% | 9% | 12% |
| Other Income | 19 | 11 | 9 | 31 | 19 | 20 | 42 | 60 | 34 | 42 | -10 | 42 | 43 |
| Interest | 92 | 96 | 82 | 95 | 91 | 105 | 103 | 119 | 104 | 140 | 127 | 156 | 132 |
| Depreciation | 47 | 51 | 55 | 58 | 61 | 86 | 88 | 86 | 86 | 90 | 102 | 126 | 106 |
| PBT | -159 | 120 | 154 | 26 | 13 | 337 | 289 | 238 | 424 | 469 | 233 | 202 | 526 |
| Tax % | -25% | 26% | 29% | 18% | 59% | 24% | 28% | 28% | 25% | 27% | 22% | 23% | 25% |
| Net Profit | -120 | 89 | 109 | 22 | 5 | 255 | 209 | 172 | 317 | 342 | 182 | 156 | 393 |
| EPS in Rs | -1.47 | 1.1 | 1.34 | 0.26 | 0.07 | 3.13 | 2.57 | 2.11 | 3.88 | 4.19 | 1.75 | 1.5 | 3.78 |
Profit & Loss
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,358 | 4,193 | 5,165 | 7,859 | 13,341 | 11,575 | 13,820 | 21,826 | 23,447 |
| Expenses | 3,906 | 3,726 | 4,616 | 7,175 | 12,525 | 10,903 | 12,549 | 19,675 | 21,155 |
| Operating Profit | 452 | 467 | 549 | 684 | 816 | 672 | 1,271 | 2,152 | 2,292 |
| OPM % | 10% | 11% | 11% | 9% | 6% | 6% | 9% | 10% | 10% |
| Other Income | 29 | 27 | 12 | 27 | 76 | 45 | 96 | 107 | 116 |
| Interest | 159 | 192 | 111 | 86 | 291 | 366 | 362 | 528 | 555 |
| Depreciation | 70 | 72 | 83 | 90 | 175 | 211 | 252 | 403 | 423 |
| PBT | 251 | 230 | 366 | 535 | 426 | 141 | 752 | 1,328 | 1,430 |
| Tax % | 37% | 16% | 39% | 26% | 29% | 29% | 27% | 25% | — |
| Net Profit | 159 | 193 | 223 | 398 | 304 | 100 | 552 | 996 | 1,072 |
| EPS in Rs | 276 | 336 | 388 | 6.92 | 3.73 | 1.23 | 6.77 | 9.6 | 11.22 |
| Div. Payout % | 36% | 0% | 0% | 0% | 13% | 41% | 15% | 16% | — |
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 575 | 575 | 575 | 575 | 814 | 815 | 815 | 1,038 |
| Reserves | 907 | 1,028 | 1,252 | 1,650 | 2,690 | 2,750 | 3,262 | 5,745 |
| Borrowings | 3,123 | 2,298 | 1,251 | 2,954 | 4,648 | 4,014 | 4,358 | 6,906 |
| Other Liabilities | 1,022 | 1,109 | 1,344 | 2,749 | 2,504 | 2,083 | 2,711 | 4,247 |
| Total Liabilities | 5,628 | 5,010 | 4,423 | 7,928 | 10,657 | 9,661 | 11,146 | 17,936 |
| Fixed Assets | 1,024 | 1,214 | 1,226 | 1,261 | 2,872 | 3,431 | 3,349 | 6,026 |
| CWIP | 255 | 149 | 220 | 336 | 697 | 372 | 553 | 424 |
| Investments | 0 | 3 | 125 | 553 | 3 | 3 | 272 | 25 |
| Other Assets | 4,349 | 3,644 | 2,852 | 5,778 | 7,085 | 5,855 | 6,972 | 11,461 |
| Total Assets | 5,628 | 5,010 | 4,423 | 7,928 | 10,657 | 9,661 | 11,146 | 17,936 |
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating | -920 | 1,270 | 1,501 | -44 | -2,377 | 1,437 | 1,386 | -1,012 |
| Investing | -103 | -143 | -289 | -1,099 | -419 | -367 | -597 | -558 |
| Financing | 1,018 | -1,141 | -1,124 | 1,589 | 2,301 | -1,022 | -6 | 998 |
| Net Cash Flow | -5 | -15 | 87 | 446 | -495 | 48 | 783 | -571 |
| Free Cash Flow | -1,047 | 1,131 | 1,332 | -664 | -2,812 | 1,026 | 1,018 | -1,878 |
| CFO/OP | -196 | 278 | 288 | 6 | -274 | 222 | 120 | -34 |
Ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 196 | 187 | 82 | 42 | 101 | 86 | 67 | 80 |
| Inventory Days | 166 | 134 | 85 | 133 | 77 | 74 | 82 | 105 |
| Days Payable | 83 | 100 | 89 | 132 | 66 | 60 | 72 | 70 |
| Cash Conversion Cycle | 280 | 221 | 78 | 43 | 112 | 100 | 76 | 115 |
| Working Capital Days | 35 | 33 | 25 | -50 | 14 | 13 | -7 | 18 |
| ROCE % | — | 10% | 14% | 15% | 11% | 7% | 14% | 17% |
Documents
Frequently Asked Questions about Paradeep Phosphates Ltd
What does Paradeep Phosphates Ltd do?
Where is Paradeep Phosphates Ltd (PARADEEP) listed?
Which sector does Paradeep Phosphates Ltd belong to?
What is the market capitalisation of Paradeep Phosphates Ltd?
What is the PE ratio of Paradeep Phosphates Ltd?
What is the 52-week high and low of Paradeep Phosphates Ltd?
Does Paradeep Phosphates Ltd pay dividends?
What is the Return on Equity (ROE) of Paradeep Phosphates Ltd?
How can I research Paradeep Phosphates Ltd on Tapetide?
Company Information
Incorporated in 1981, Paradeep Phosphates Limited is a manufacturer of non-urea fertilizers and India’s second largest private sector phosphatic company. The company is engaged in manufacturing, trading, distribution, and sales of a variety of complex fertilizers such as DAP, three grades of Nitrogen-Phosphorus-Potassium (namely NPK-10, NPK-12, and NP-20), Zypmite, Phospho-gypsum, and Hydroflorosilicic Acid.[1]